An investigation on behalf of investors in Poseida Therapeutics, Inc. (NASDAQ:PSTX) shares over potential wrongdoing at Poseida Therapeutics, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 12/17/2020 -- An investigation was announced concerning possible breaches of fiduciary duties by certain directors at Poseida Therapeutics, Inc.
Investors who purchased shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Poseida Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Diego, CA based Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs.
Poseida Therapeutics, Inc. (NASDAQ: PSTX) completed its initial public offering ("IPO") on July 10, 2020, issuing 14 million shares of common stock at $16.00 per share.
Poseida Therapeutics, Inc. then disclosed on August 18, 2020, that the FDA had placed a clinical hold on its Phase 1 clinical trial of the autologous CAR-T therapy P-PSMA-101 in patients with metastatic castration-resistant prostate cancer. The hold is reportedly to investigate a patient's death that occurred in July.
Shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) declined to as low as $7.63 per share on August 24, 2020.
Those who purchased shares of Poseida Therapeutics, Inc. (NASDAQ: PSTX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.